Fiedler, W., & Kayser, S. (2015). A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations. British journal of haematology, 169(5), . https://doi.org/10.1111/bjh.13353
Chicago-Zitierstil (17. Ausg.)Fiedler, Walter, und Sabine Kayser. "A Phase I/II Study of Sunitinib and Intensive Chemotherapy in Patients over 60 Years of Age with Acute Myeloid Leukaemia and Activating FLT3 Mutations." British Journal of Haematology 169, no. 5 (2015). https://doi.org/10.1111/bjh.13353.
MLA-Zitierstil (9. Ausg.)Fiedler, Walter, und Sabine Kayser. "A Phase I/II Study of Sunitinib and Intensive Chemotherapy in Patients over 60 Years of Age with Acute Myeloid Leukaemia and Activating FLT3 Mutations." British Journal of Haematology, vol. 169, no. 5, 2015, https://doi.org/10.1111/bjh.13353.